Inhibitory activity of HIV envelope gp120 dominates over its antigenicity for human T cells

Clin Exp Immunol. 1992 Apr;88(1):17-22. doi: 10.1111/j.1365-2249.1992.tb03032.x.

Abstract

HIV-1 envelope glycoprotein (gp120), as a CD4-binding reactant, has been shown to inhibit in its native form human T cell responses to several antigens. Here we show that gp120 in soluble form also inhibits activation of a specific human T cell line that responds to gp120-pulsed autologous antigen-presenting cells. In addition the inhibitory property of gp120 for antigen-driven T cell proliferation depends upon its ability to bind CD4 and is lost when CD4-binding capacity is abolished by denaturation, or blocked by complexing with soluble CD4 or with polyclonal antibodies. In contrast, antigenicity of denatured or complexed gp120 for specific human T cells is preserved. Similar effects are also observed with another CD4-binding reactant (i.e. anti-Leu 3a MoAb), which stimulates and/or inhibits human T cells specific for mouse immunoglobulins depending on native or denatured conformation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal / immunology
  • Antigens, Differentiation / physiology
  • CD4 Antigens / physiology
  • Cell Line
  • Clone Cells
  • HIV Envelope Protein gp120 / immunology*
  • Humans
  • Lymphocyte Activation
  • Protein Denaturation
  • T-Lymphocytes / drug effects*
  • T-Lymphocytes / immunology

Substances

  • Antibodies, Monoclonal
  • Antigens, Differentiation
  • CD4 Antigens
  • HIV Envelope Protein gp120